The Karnofsky Performance Status (KPS) scale is a standardized tool used to assess a cancer patient’s ability to perform daily activities. It is a key measure of functional status, guiding clinicians in prognosis, treatment decisions, and palliative care planning. A higher score = better independence and tolerance of therapy.

📊 Scale Description

The KPS scale ranges from 0 to 100 in intervals of 10. It evaluates a patient’s ability to work, self-care, and need for assistance.

💯 100% – Normal; no complaints; no disease.
💪 90% – Normal activity; minor symptoms.
🙂 80% – Normal activity with effort; some symptoms.
🧍 70% – Cares for self; unable to work.
🤝 60% – Needs occasional assistance.
🩺 50% – Requires considerable help and medical care.
♿ 40% – Disabled; needs special assistance.
🏥 30% – Severely disabled; hospitalised but not moribund.
⚠️ 20% – Very sick; hospitalised, active treatment required.
☠️ 10% – Moribund; fatal processes advancing rapidly.
🕊️ 0% – Dead.

🔎 Interpretation

💯–80–100%: Independent, able to work; minimal/no support needed.
🤝–50–70%: Unable to work, but self-care partly possible; needs assistance.
🏥–0–40%: Dependent; requires hospital/institutional care.

⚕️ Clinical Use

📈 Prognosis: Higher scores → longer survival & better tolerance of treatment.
💊 Treatment planning: Determines suitability for chemo, radiotherapy, surgery.
🔁 Monitoring: Tracks functional decline or recovery → guides transition to supportive/palliative care.
🧪 Research: Used in clinical trials to stratify patients and assess outcomes.

✅ Advantages

⏱ Quick and simple to administer.
📏 Provides a standardised comparison across patients & settings.
🤝 Improves communication among multidisciplinary teams.

⚠️ Limitations

👩‍⚕️ Subjective scoring → inter-observer variability.
🧠 Misses psychosocial/quality of life dimensions.
📉 Less sensitive to subtle but clinically important changes.

📌 Comparison with ECOG

The Eastern Cooperative Oncology Group (ECOG) scale is another widely used tool. It ranges from 0 to 5 (fewer levels than KPS). KPS offers finer gradation (11 levels) for more detailed functional assessment, whereas ECOG is simpler and often preferred in trials.

📝 Summary

The KPS scale remains a cornerstone of oncology assessment. It quantifies independence, predicts prognosis, informs treatment tolerance, and supports care planning. Regular use enhances patient-centred care and improves team communication.

📚 References

Karnofsky DA et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1948;1(4):634-656.
National Cancer Institute. Karnofsky Performance Status definition.
Mitchell AJ. A meta-analysis of the accuracy of the MMSE in dementia detection. J Psychiatr Res. 2009;43(4):411-431.

The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms.

Karnofsky performance status scale

🌟 Introduction